Fcf Advisors LLC Alkermes Plc. Transaction History
Fcf Advisors LLC
- $689 Million
- Q4 2025
A detailed history of Fcf Advisors LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Fcf Advisors LLC holds 219,495 shares of ALKS stock, worth $6.37 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
219,495Holding current value
$6.37 Million% of portfolio
0.92%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
408Shares Held
179MCall Options Held
901KPut Options Held
400K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18MShares$523 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...